【24h】

OUTCOME

机译:结果

获取原文

摘要

Both sessions of the second day focused on correlation of antibody testing results and transplant outcome. The first session started with a discussion of the autoimmune and alloimmune responses in transplant outcome and the correlation with detection of non-HLA specific antibodies as well as donor HLA specific antibodies (DHSA). Dr. Mohanakumar presented studies of chronic rejection in lung transplant, defined clinically as bronchiolitis obliterans syndrome (BOS). They followed the post-transplant development of HLA specific antibodies as well as antibodies to self antigens, K a 1 tubulin and collagen V. The authors observed that the development of donor HLA specific antibodies preceded the development of BOS. Further, these patients also developed antibodies to the self antigens, which persisted even if there were no detectable DHSA. Antibodies to the self antigens myosin, collagen V, and vimentin were found increased with antibody mediated rejection (AMR) in cardiac transplantation. Antibodies to collagen IV and vimentin were found increased with chronic changes in kidney transplantation.
机译:第二天的两届会议的重点是抗体检测结果和移植结果的相关性。第一届会议开始讨论移植结果中的自身免疫和同种异性反应以及与检测非HLA特异性抗体以及供体HLA特异性抗体(DHSA)的相关性。 Mohanakumar博士提出了肺移植慢性排斥反应的研究,临床上定义为支气管炎梗阻症综合征(BOS)。他们跟随HLA特异性抗体的后移植后发育以及自我抗原的抗体,K A 1微管蛋白和胶原V.作者观察到供体HLA特异性抗体的发育在Bos的发育之前。此外,这些患者还开发了对自我抗原的抗体,即使没有可检测的DHSA,也持续存在。发现对自我抗原肌蛋白,胶原蛋白V和Vimentin的抗体随着心脏移植的抗体介导的抑制(AMR)增加。发现对胶原蛋白IV和Vimentin的抗体随着肾移植的慢性变化而增加。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号